Himadri Speciality Chemical Q1 Results FY27: Net Profit Rises 26.3% to Rs 230 Crore, Approves Rs 368 Crore Capex

Himadri Speciality Chemical Q1 results FY27 were announced on Wednesday, 15 July 2026, with the carbon black and speciality chemicals maker reporting a consolidated net profit of Rs 230 crore, up 26.3% from Rs 182 crore in the year ago quarter. Revenue in the Himadri Speciality Chemical Q1 results FY27 grew 28% year on year to Rs 1,432 crore from Rs 1,118 crore, while EBITDA rose a slower 17.6% to Rs 287.9 crore, with the EBITDA margin contracting to 20.1% from 21.9%.

Alongside the results, the board approved a combined Rs 368 crore in capital expenditure across three projects: Rs 170 crore for manufacturing Super Speciality Carbon Black, Rs 128 crore for capacity addition, and Rs 70 crore for Carbon Nano Tubes. Shares of Himadri Speciality Chemical rose 1.51% to close at Rs 681.55.

Click Here – Get Free Investment Predictions

Himadri Speciality Chemical Q1 results FY27 Financial Highlights

The June quarter delivered strong revenue growth alongside margin compression, even as other income provided a meaningful boost to the bottom line, a combination worth understanding before reading the Himadri Speciality Chemical Q1 results FY27 table below. The table below summarises the consolidated numbers against the year ago quarter.

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 1,432 Cr	Rs 1,118 Cr	+28%
EBITDA	Rs 287.9 Cr	Rs 244.9 Cr	+17.6%
EBITDA Margin	20.1%	21.9%	-180 bps
Other Income	Rs 56.3 Cr	Rs 26.7 Cr	+111%
Net Profit (PAT)	Rs 230 Cr	Rs 182 Cr	+26.3%

Other income more than doubling to Rs 56.3 crore from Rs 26.7 crore in the Himadri Speciality Chemical Q1 results FY27 contributed meaningfully to the strong PAT growth, helping offset the roughly 180 basis point contraction in EBITDA margin.

Himadri Speciality Chemical Q1 results FY27 Performance Analysis

Get Personalised Guidance from a SEBI-Registered Investment Advisor

The gap between revenue growth of 28% and EBITDA growth of 17.6% in the Himadri Speciality Chemical Q1 results FY27 shows margin compression at the operating level, likely from higher input costs for coal tar pitch and other raw materials used in carbon black production, even as volumes grew strongly.

The sharp jump in other income, more than doubling to Rs 56.3 crore, played an important role in supporting overall PAT growth of 26.3% despite the EBITDA margin decline, and investors should note that a portion of this quarter’s profit growth is not purely operational in nature.

The Rs 368 crore capex approval spanning Super Speciality Carbon Black, general capacity addition, and Carbon Nano Tubes signals the company’s continued investment in higher-value, differentiated product lines beyond its core carbon black business, a strategic direction that could support margin recovery over the medium term as these newer capacities come online.

Himadri Speciality Chemical Q1 results FY27: Key Business Factors

1. Margin Pressure from Input Costs

EBITDA margin contracting to 20.1% from 21.9% in the Himadri Speciality Chemical Q1 results FY27 points to rising raw material costs, particularly coal tar pitch, a key input for carbon black manufacturing that can be volatile.

2. Major Capex Push into Speciality Products

The approved Rs 170 crore investment in Super Speciality Carbon Black and Rs 70 crore in Carbon Nano Tubes, confirmed in the Himadri Speciality Chemical Q1 results FY27, reflects a strategic shift toward higher-margin, differentiated chemical products beyond commodity carbon black.

3. Strong Other Income Contribution

Other income more than doubling to Rs 56.3 crore was a significant contributor to the Himadri Speciality Chemical Q1 results FY27 bottom line, a factor investors should distinguish from the core operating performance when assessing quality of earnings.

Dividend Details

No new dividend was announced specifically alongside the Himadri Speciality Chemical Q1 results FY27. With significant capex now approved across three projects, near-term capital allocation is likely to prioritise funding this expansion rather than shareholder payouts.

Himadri Speciality Chemical Q1 results FY27 Outlook for the Full Year

The Rs 368 crore capex programme across Super Speciality Carbon Black, capacity addition and Carbon Nano Tubes positions the company for longer-term growth in higher-margin speciality chemical segments, though the benefits will take time to materialise as these projects are commissioned. Investors should track raw material cost trends, the timeline for the new capacity coming online, and whether EBITDA margins stabilise in coming quarters.

Himadri Speciality Chemical Stock Performance After the Q1 Results

Download the Univest iOS App or Univest Android App to track Himadri Speciality Chemical live share price and upcoming quarterly results.

Himadri Speciality Chemical share price rose 1.51% to close at Rs 681.55 on the NSE after the Himadri Speciality Chemical Q1 results FY27, touching an intraday high of Rs 684.50 during the session.

The modest positive stock reaction suggests the market welcomed both the profit growth and the capex announcement, while also factoring in the margin compression that tempered enthusiasm for the headline revenue growth.

Key Risks

Investors going through the fine print of the Himadri Speciality Chemical Q1 results FY27 should also weigh the following risks before drawing firm conclusions.

1. Raw Material Cost Volatility

Coal tar pitch and other key inputs for carbon black production can be volatile, tied to steel and coking coal industry dynamics, and continued cost pressure could further compress margins.

2. Capex Execution Risk

The Rs 368 crore capex programme approved this quarter carries typical execution risks, including project delays, cost overruns, and the time needed for new capacity to ramp up to full utilisation.

3. Dependence on Non-Operating Income

With other income contributing meaningfully to profit growth in the Himadri Speciality Chemical Q1 results FY27, sustainability of the current PAT trajectory partly depends on a less predictable income source compared with the core operating business.

Conclusion

Himadri Speciality Chemical Q1 results FY27 show PAT up 26.3% to Rs 230 crore and revenue up 28% to Rs 1,432 crore, though EBITDA margin contracted to 20.1% and a sizeable other income contribution supported the bottom line. The Rs 368 crore capex approval across speciality carbon black and Carbon Nano Tubes is the strategic highlight this quarter, against near-term margin pressure. Investors reading the Himadri Speciality Chemical Q1 results FY27 should track the new capacity timeline and consult a SEBI-registered advisor before acting on the numbers.

Frequently Asked Questions on Himadri Speciality Chemical Q1 results FY27

When were the Himadri Speciality Chemical Q1 results FY27 announced?

Ans. The Himadri Speciality Chemical Q1 results FY27 were announced on Wednesday, 15 July 2026, for the quarter ended 30 June 2026.

What is the PAT in Himadri Speciality Chemical Q1 results FY27?

Ans. The consolidated PAT in Himadri Speciality Chemical Q1 results FY27 rose 26.3% year on year to Rs 230 crore from Rs 182 crore.

What was the revenue in Himadri Speciality Chemical Q1 results FY27?

Ans. Revenue in the Himadri Speciality Chemical Q1 results FY27 grew 28% year on year to Rs 1,432 crore from Rs 1,118 crore.

What capex did Himadri Speciality Chemical approve with its Q1 results FY27?

Ans. Alongside the Himadri Speciality Chemical Q1 results FY27, the board approved Rs 170 crore for manufacturing Super Speciality Carbon Black, Rs 128 crore for capacity addition, and Rs 70 crore for Carbon Nano Tubes, totalling Rs 368 crore.

Why did EBITDA margin fall in Himadri Speciality Chemical Q1 results FY27?

Ans. EBITDA margin in the Himadri Speciality Chemical Q1 results FY27 fell to 20.1% from 21.9% a year earlier, likely reflecting higher input costs for coal tar pitch and other raw materials used in carbon black production.

How did Himadri Speciality Chemical share price react to the Q1 results FY27?

Ans. Himadri Speciality Chemical share price rose 1.51% to close at Rs 681.55 on the NSE after the Himadri Speciality Chemical Q1 results FY27.

Is Himadri Speciality Chemical a good buy after the Q1 results FY27?

Ans. The Himadri Speciality Chemical Q1 results FY27 show strong revenue growth and a major capex push into speciality chemicals, though margin compression and capex execution risk are factors to watch. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.